Survivin downregulation by siRNA/cationic liposome complex radiosensitises human hepatoma cells in vitro and in vivo

First human dose study evaluating safety and pharmacokinetics of LY2181308, an antisense oligonucleotide designed to inhibit survivin

(2017) D. C. Talbot et al.   JOURNAL OF CLINICAL ONCOLOGY

Survivin: A new target for anti-cancer therapy

(2009) Bríd M. Ryan et al.   CANCER TREATMENT REVIEWS

Inhibiting XIAP expression by RNAi to inhibit proliferation and enhance radiosensitivity in laryngeal cancer cell line

(2008) Rui Wang et al.   AURIS NASUS LARYNX

Progress in developing cationic vectors for non-viral systemic gene therapy against cancer

(2008) Marie Morille et al.   BIOMATERIALS

Survivin Antisense Oligonucleotides Effectively Radiosensitize Colorectal Cancer Cells in Both Tissue Culture and Murine Xenograft Models

(2008) Franz Rödel et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Silencing survivin gene expression promotes apoptosis of human breast cancer cells through a caspase-independent pathway

(2008) Diego O. Croci et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Efficient inhibition of murine breast cancer growth and metastasis by gene transferred mouse survivin Thr34→Ala mutant

(2008) Xing-Chen Peng et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Clinical and immunological evaluation of anti-apoptosis protein, survivin-derived peptide vaccine in phase I clinical study for patients with advanced or recurrent breast cancer

(2008) Tetsuhiro Tsuruma et al.   Journal of Translational Medicine

Survivin gene RNA interference inhibits proliferation, induces apoptosis, and enhances radiosensitivity in HeLa cells

(2006) Hui Song et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology